RT: Why @Novartis lost its treatment dispute with @TevaUSA The pharma firm’s arguments failed to convince a London cour… https://t.co/plFtfUvMVD

@IAM_Alerts have published an article discussing the incoming EU CHIPS Act and the exciting opportunities this will… https://t.co/BgZ01fbyYD